Stock RCM R1 RCM INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials R1 RCM Inc. Nasdaq

Equities

RCM

US7493971052

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 01:30:00 06/07/2024 am IST 		5-day change 1st Jan Change
10.95 USD -1.62% Intraday chart for R1 RCM Inc. -12.82% -53.64%
03/07 Financial Shares Edge Lower -- Financials Roundup DJ
03/07 PE firm New Mountain values R1 RCM at nearly $6 bln in take-private deal RE

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,465 2,802 7,046 4,561 4,432 4,613 - -
Enterprise Value (EV) 1 1,727 3,180 7,689 6,237 5,896 6,550 6,228 5,775
P/E ratio -162 x 72.8 x 69.8 x -68.4 x 1,057 x -63.2 x 88.6 x 38.1 x
Yield - - - - - - - -
Capitalization / Revenue 1.24 x 2.21 x 4.78 x 2.52 x 1.97 x 1.77 x 1.58 x 1.44 x
EV / Revenue 1.46 x 2.5 x 5.21 x 3.45 x 2.62 x 2.51 x 2.13 x 1.8 x
EV / EBITDA 10.3 x 13.3 x 22.4 x 14.7 x 9.6 x 10.2 x 8.08 x 6.56 x
EV / FCF 32.6 x 254 x 36.1 x -60.3 x 24.8 x 38 x 23 x 14.2 x
FCF Yield 3.06% 0.39% 2.77% -1.66% 4.03% 2.63% 4.35% 7.05%
Price to Book 81.8 x - 20.5 x 1.2 x 1.74 x 1.62 x 1.49 x 1.32 x
Nbr of stocks (in thousands) 1,12,865 1,16,662 2,76,434 4,16,511 4,19,308 4,21,255 - -
Reference price 2 12.98 24.02 25.49 10.95 10.57 10.95 10.95 10.95
Announcement Date 20/02/20 18/02/21 17/02/22 16/02/23 27/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,186 1,271 1,475 1,806 2,254 2,611 2,918 3,209
EBITDA 1 168 240 343.6 425.5 614.3 644.1 770.7 879.8
EBIT 1 57.7 80 145.7 3 147.9 89.84 236.4 349.9
Operating Margin 4.86% 6.3% 9.88% 0.17% 6.56% 3.44% 8.1% 10.91%
Earnings before Tax (EBT) 1 9.8 118.4 126.8 -61 21 -86.77 84.52 217.6
Net income 1 -8.7 117.1 97.2 -57.6 3.3 -79.23 49.6 122.4
Net margin -0.73% 9.21% 6.59% -3.19% 0.15% -3.03% 1.7% 3.81%
EPS 2 -0.0800 0.3300 0.3652 -0.1600 0.0100 -0.1732 0.1236 0.2874
Free Cash Flow 1 52.9 12.5 213.1 -103.4 237.6 172.2 271.2 407
FCF margin 4.46% 0.98% 14.45% -5.72% 10.54% 6.6% 9.29% 12.68%
FCF Conversion (EBITDA) 31.49% 5.21% 62.02% - 38.68% 26.74% 35.19% 46.26%
FCF Conversion (Net income) - 10.67% 219.24% - 7,200% - 546.82% 332.6%
Dividend per Share 2 - - - - - - - -
Announcement Date 20/02/20 18/02/21 17/02/22 16/02/23 27/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 398.9 385.7 391.9 496 532.8 545.6 560.7 572.8 575.1 603.9 637.4 657 713.1 688.3 719.5
EBITDA 1 95.1 89.3 87.2 124 125 142.2 142.9 161.5 167.7 152.2 152.4 152.6 188.3 175.7 188.7
EBIT 1 50.2 43.2 -38 2 -4.2 33.7 23.9 41.2 49.1 8 13.85 19.65 47.9 43.1 41.65
Operating Margin 12.58% 11.2% -9.7% 0.4% -0.79% 6.18% 4.26% 7.19% 8.54% 1.32% 2.17% 2.99% 6.72% 6.26% 5.79%
Earnings before Tax (EBT) 1 45.1 38.5 -44.9 -21.7 -32.9 3 -8.6 9.1 17.5 -33.3 -27.37 -24.63 -0.5191 -6.464 -0.7172
Net income 1 36 29.4 -20.4 -29.5 -37.1 0.3 0.3 1.3 1.4 -35.1 -22.77 -25.13 3.97 -5.983 0.1374
Net margin 9.02% 7.62% -5.21% -5.95% -6.96% 0.05% 0.05% 0.23% 0.24% -5.81% -3.57% -3.82% 0.56% -0.87% 0.02%
EPS 2 0.1100 0.0900 -0.0700 -0.0700 -0.0900 0.000700 - - 0.003100 -0.0800 -0.0477 -0.0486 0.009350 -0.008650 0.008210
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 17/02/22 09/05/22 03/08/22 08/11/22 16/02/23 04/05/23 02/08/23 02/11/23 27/02/24 08/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 262 378 642 1,676 1,464 1,937 1,616 1,162
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.56 x 1.576 x 1.869 x 3.94 x 2.383 x 3.007 x 2.096 x 1.321 x
Free Cash Flow 1 52.9 12.5 213 -103 238 172 271 407
ROE (net income / shareholders' equity) 98.4% 108% 44.7% -3.76% 0.12% -0.52% 2.92% 5.24%
ROA (Net income/ Total Assets) 9.84% 5.38% 7.37% -1.75% 0.07% -1.63% 0.02% 0.97%
Assets 1 -88.46 2,176 1,319 3,295 5,038 4,847 2,43,982 12,666
Book Value Per Share 2 0.1600 - 1.250 9.120 6.060 6.760 7.360 8.280
Cash Flow per Share 2 - - 0.9900 -0.0300 0.7500 0.6100 1.210 1.390
Capex 1 61 49.3 51.7 93.5 103 120 139 152
Capex / Sales 5.14% 3.88% 3.51% 5.18% 4.55% 4.61% 4.77% 4.75%
Announcement Date 20/02/20 18/02/21 17/02/22 16/02/23 27/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for R1 RCM Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
10.95 USD
Average target price
16.57 USD
Spread / Average Target
+51.34%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.33% 8.39TCr
CVS HEALTH CORPORATION Stock CVS Health Corporation
-28.29% 7.11TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+0.99% 2.68TCr
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+3.67% 1.77TCr
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-9.99% 1.72TCr
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+1.86% 1.56TCr
NATERA, INC. Stock Natera, Inc.
+79.98% 1.38TCr
PURE HEALTH HOLDING Stock Pure Health Holding
-25.09% 1.29TCr
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+74.41% 1.29TCr
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. RCM Stock
  4. RCM Stock
  5. Financials R1 RCM Inc.